longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Healthcare stocks with the strongest dividend growth grades

MSN
Sep 21, 2026 at 10:48 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Seeking Alpha ranks the top 19 healthcare stocks by Dividend Growth Grade, evaluating consistency and magnitude of dividend increases. Six companies—Chemed, Gilead Sciences, HCA Healthcare, Eli Lilly, ResMed, and West Pharmaceutical Services—achieved the highest A+ grade. Bristol-Myers Squibb and Stryker received A grades, while the remaining firms hold A- grades. This screening helps investors identify companies with strong capital return histories within the diverse healthcare sector.

Healthcare stocks remain an important part of the market as investors weigh resilient demand, healthcare spending and the earnings outlook across pharmaceuticals, medical devices, healthcare services and life sciences. Within the sector, dividend growth can provide an additional lens for investors assessing companies that have demonstrated a consis...

Login to unlock353characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Apr 20, 2026 at 06:34 PMEli Lilly Announces $7 Billion Acquisition of Kelonia: Pioneering the 'In Vivo CAR-T' Frontier and Leading Gene Therapy …
  • Apr 1, 2026 at 11:11 PMEli Lilly's Oral Weight-Loss Drug Foundayo Approved, the Only One That Can Be Taken Anytime Without Fasting
  • Apr 1, 2026 at 01:21 PMFrom Weight-Loss Drugs to Sleep Disorders! Lilly Plans to Acquire Centessa for Up to $7.8 Billion, Entering Narcolepsy a…
  • Feb 24, 2026 at 01:55 PMNovo Nordisk will significantly reduce the price of its weight loss drug in the U.S. next year, with a maximum reduction…
  • Feb 23, 2026 at 11:17 PMA single pen covering the full month's dosage! Eli Lilly launches Zepbound multi-dose injection pen starting at $299

Related Stocks

Resmed

Resmed

USRMD

-1.02%

HCA Healthcare

HCA Healthcare

USHCA

+0.78%

Gilead Sciences

Gilead Sciences

USGILD

-1.87%

LongbridgeAI